PEGylated Proteins Market worth 1,137.8 Million USD by 2021


Posted March 8, 2017 by mmvaidya01

The global PEGylated proteins market is expected to reach USD 1,137.8 Million by 2021 from USD 690.6 Million in 2016, at a CAGR of 10.5% from 2016 to 2021.

 
Browse 87 market data tables and 65 figures spread through 176 pages and in-depth TOC on “PEGylated Proteins Market”
http://www.marketsandmarkets.com/Market-Reports/pegylated-protein-market-19242378.html
Early buyers will receive 10% customization on this report.

Asia presents huge opportunities for the growth of PEGylated proteins owing to rising government support and increasing number of agreement & collaborations between foreign pharmaceutical companies and local research laboratories in the region. The wide applications of PEGylated proteins in treating cancer, blood disorder, chronic and autoimmune disease are driving factors of the PEGylated proteins market.

Meanwhile, growing adoption and upgradation of new products, including PEGylation reagents and kits, is a key focus area by many players in emerging countries PEGylated proteins market. The new reagents such as biodegradable polymers, PEG linkers offer significant opportunities by providing tremendous impetus on the ongoing research in the area of drug delivery technology, due to their capability to provide a biomaterial having a broad range of amphiphilic characteristics, as well as targeting the drugs to specific site.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=19242378

PEGylation is versatile drug delivery technique that shows conjugation of polyethylene glycol (PEG) polymer chains to another molecule, normally to a therapeutic protein, peptide or non-peptide molecule. PEG reagents are commercially available in different lengths, shapes, and chemistries, allowing them to react with particular functional groups of proteins for their covalent attachment. These reagents are used in various applications including oncology, blood disorders, chronic and autoimmune diseases, and viral diseases.

North America accounted for the largest share of the global PEGylated Proteins market in 2016. However, the Asian market is expected to grow at the highest rate during the forecast period and represents new revenue pockets for the PEGylated Proteins market. Asian region comprises countries such as Indonesia, Singapore, Thailand, China, India, Japan, and South Korea among others.

Speak to Research Analyst:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=19242378

However, a major part of the revenue in the Asian PEGylated protein market will be coming from Japan, China and India. As many companies are increasing R&D investment in these countries and also many big biopharma players are establishing its R&D departments in this region. In second place is North America while Europe accounted for lowest share as compared to other Asia & North America. Government support in form of grant and conferences related to therapeutic proteins is expected to be one of the major factors driving the demand for PEGylated proteins in the APAC region.

The major players in this market include Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), NOF Corporation (Japan), JenKem Technology USA, Inc. (U.S.), Creative PEGworks (U.S), Celares GmbH (Germany), Quanta BioDesign, Ltd. (U.S.), Biomatrik, Inc, (China), Iris Biotech GmbH (Germany), Laysan Bio, Ltd. (U.S.).

About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Research , Science
Tags global pegylated proteins market , pegylated proteins , pegylated proteins market
Last Updated March 8, 2017